chat
Defining Access By Design in R&D For Diagnostics, Therapeutics, And Vaccines
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.
‘This session will reflect on the WHO’s renewed pathogen family strategy, discussing how researchers and organizations can strengthen a collaborative and equitable approach at national, regional and global levels. It will identify potential gaps, what collaborations already exist, and what new actions need to be taken so that the world can expand access to scientific and technological tools for researchers around the world and enable equitable access.’